Sol-Gel Technologies Ltd. (SLGL) Financials

SLGL Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 58.6 million 7.1 million
Dec. 31, 2025 29.9 million 7.1 million
Sept. 30, 2025 34.6 million 8.6 million
June 30, 2025 39.3 million 7.4 million

SLGL Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 ? ?
Dec. 31, 2025 ? ?
Sept. 30, 2025 ? ?
June 30, 2025 ? ?

SLGL Net Income

No data available :(

SLGL Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 52.8 million - 862000
Dec. 31, 2025 24.0 million - 496000
Sept. 30, 2025 20.8 million - 592000
June 30, 2025 24.3 million - 1.2 million

SLGL Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 2.8 million
Dec. 31, 2025 2.8 million
Sept. 30, 2025 2.8 million
June 30, 2025 2.8 million

SLGL Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 2.8 million 1.2 million -
Dec. 31, 2025 - 3.6 million 577000 -
Sept. 30, 2025 - 5.7 million 957000 -
June 30, 2025 - 4.6 million 1.4 million -

SLGL Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 108000 -
Dec. 31, 2025 696000 -
Sept. 30, 2025 400000 -
June 30, 2025 17.3 million -

SLGL Revenue by Segment

Graph available only for paid members. Upgrade to see it.

SLGL

Price: $73.44

52 week price:
6.80
97.97

Earnings Per Share: -0.30 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 22900

Market Capitalization: 219.1 million

Links: